15 results found.

Nasopharyngeal Carcinoma Clinical Trial using Drug: Gemcitabine and cisplatin; Cisplatin

First People's Hospital of Foshan - Recruiting 18 years to 60 years.
- Randomized Phase ? Trial of Induction Chemotherapy Using Gemcitabine and Cisplatin in Concurrence With Intensity-modulated Radiotherapy for Locoregionally Advanced Nasopharyngeal Carcinoma.
Drug: Gemcitabine and cisplatin; Cisplatin

Nasopharyngeal Carcinoma, or Radiation Therapy Complication Clinical Trial using Atorvastatin; Placebo

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University - Recruiting 40 years to 65 years.
- Atorvastatin in Preventing Nasopharyngeal Carcinoma Patients Receiving Radiotherapy From Carotid Stenosis: A Multicenter, Double-blind, Placebo-Controlled, Randomized Trial.
Atorvastatin; Placebo

Nasopharyngeal Carcinoma Clinical Trial using OPB-51602

National University Hospital, Singapore - Recruiting 21 years or older.
- The Signal Transducer and Activator of Transcription (STAT)3 Pathway and the Development of STAT3 Phosphorylation Inhibitors as Cancer Therapy: Lead-In Phase I Dose-Escalating, Open-Label, Non-Randomised Study of A Weekly Regimen OPB-51602 in Advanced Refractory Solid Tumours With Enrichment Cohorts of Nasopharyngeal Carcinoma Followed By A Biomarker Study Evaluating OPB-51602 in Locally Advanced Nasopharyngeal Carcinoma Prior to Definitive Chemoradiotherapy.
OPB-51602

Effects of Chemotherapy, or Stage IVC Nasopharyngeal Carcinoma Clinical Trial using Recombinant Human Endostatin plus gemcitabine and cisplatin; Gemcitabine and cisplatin

Zhejiang Cancer Hospital - Recruiting 18 years to 65 years.
- A Prospective,Randomized,Controlled,Multicenter,Phase III Study of Stage ? Study of Gemcitabine Plus Cisplatin With or Without Endostatin to the Metastatic Nasopharyngeal Carcinoma.
Recombinant Human Endostatin plus gemcitabine and cisplatin; Gemcitabine and cisplatin

Nasopharyngeal Carcinoma Clinical Trial using Docetaxel; Carboplatin; Dexamethasone; EBV-specific cytotoxic T lymphocytes

Baylor College of Medicine - Recruiting 10 years or older.
- Phase II Study of Carboplatin and Docetaxel Followed by Epstein-Barr Virus Cytotoxic T Lymphocytes in Patients With Refractory/Relapsed EBV-positive Nasopharyngeal Carcinoma(CADEN).
Docetaxel; Carboplatin; Dexamethasone; EBV-specific cytotoxic T lymphocytes

Nasopharyngeal Carcinoma Clinical Trial using nitrate supplementation; Placebo

Capital Medical University - Recruiting 20 years to 60 years.
- Study of Dietary Nitrate on Plasma Nitrate Levels for Nasopharyngeal Carcinoma Patients Receiving Concurrent Chemo-radiotherapy.
nitrate supplementation; Placebo

Recurrent Squamous Cell Carcinoma of the Nasopharynx, or Stage IV Clinical Trial using Akt inhibitor MK2206; pharmacological study; laboratory biomarker analysis

National Cancer Institute (NCI) - Recruiting 18 years or older.
- Multicenter Phase II Study of MK-2206 in Previously Treated Patients With Recurrent and Metastatic Nasopharyngeal Carcinoma.
Akt inhibitor MK2206; pharmacological study; laboratory biomarker analysis

Nasopharyngeal Cancer Clinical Trial using Adjuvant chemotherapy (gemcitabine and cisplatin)

Chinese University of Hong Kong - Recruiting 18 years or older.
- A Multi-center Prospective Randomized Phase III Trial to Determine the Benefit of Adjuvant Chemotherapy Using Gemcitabine and Cisplatin in Nasopharyngeal Carcinoma Patients With Residual EBV DNA Following Primary Radiotherapy With or Without Concurrent Cisplatin.
Adjuvant chemotherapy (gemcitabine and cisplatin)

Nasopharyngeal Cancer, or Epstein Barr Virus Infections Clinical Trial using MVA-EBNA1/LMP2 vaccine

Cancer Research UK - Recruiting 18 years or older.
- A Cancer Research UK (CR-UK) Phase Ib Trial to Determine the Safety, Tolerability and Immunogenicity of Extended Schedule Vaccination With MVA-EBNA1/LMP2 in Patients With Epstein Barr Virus Positive (EBV+) Nasopharyngeal Carcinoma (NPC)..
MVA-EBNA1/LMP2 vaccine

Nasopharyngeal Neoplasms Clinical Trial using Cisplatin; Paclitaxel; IMRT

Chinese Academy of Medical Sciences - Recruiting 18 years to 70 years.
- Phase 2 Study of Inductive Plus Concurrent Chemoradiation Versus Concurrent Plus Adjuvant Chemoradiation for High-risk Locally Advanced Nasopharyngeal Carcinoma in the Era of IMRT.
Cisplatin; Paclitaxel; IMRT

Nasophayngeal Carcinoma Between Stage II and IVb Clinical Trial using cisplatin (3 weekly); cisplatin (weekly)

Samsung Medical Center - Recruiting 18 years or older.
- A Randomized Phase II Study of Concurrent Chemoradiation With Every 3 Week of Cisplatin vs With Weekly Cisplatin in Locally Advanced Nasopharyngeal Carcinoma.
cisplatin (3 weekly); cisplatin (weekly)

Nasopharyngeal Carcinoma Clinical Trial using Gemcitabine; Carboplatin; Cisplatin; 5-fluorouracil (5-FU)

Ministry of Health, Malaysia - Recruiting 18 years or older.
- An Open Labeled, Multicentre, Randomized Phase II Trial of Combination Gemcitabine and Carboplatin Chemotherapy in Patients With Metastatic or Recurrent Nasopharyngeal Carcinoma.
Gemcitabine; Carboplatin; Cisplatin; 5-fluorouracil (5-FU)

Nasopharyngeal Carcinoma Clinical Trial using docetaxel, cisplatin, fluorouracil

Fudan University - Recruiting 18 years to 70 years.
- Phase ? Study of Neoadjuvant Chemotherapy Followed by Concurrent Chemoradiation for Stage ? Nasopharyngeal Carcinoma.
docetaxel, cisplatin, fluorouracil

Nasopharyngeal Carcinoma Clinical Trial using valproic acid

Johns Hopkins University - Recruiting 18 years to 75 years.
- Valproic Acid in the Induction of EBV Lytic Cycle Antigen Expression in Nasopharyngeal Carcinoma.
valproic acid

Nasopharyngeal Carcinoma Clinical Trial

National Taiwan University Hospital - Recruiting 30 years to 65 years.
- the Garduate Institute of Microbiology in National Taiwan University.